Fundz

Poxel Appoints Yves Decadt as Chief Executive Officer

PRIVATEJun 10, 2026

Position

Chief Executive Officer

Company

Poxel

Yves Decadt
LyonBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Poxel announces the appointment of Yves Decadt as Chief Executive Officer effective June 10, 2026. He succeeds Nicolas Trouche and aims to accelerate portfolio development and strategic partnerships.

Quick answer

Poxel Appoints Yves Decadt as Chief Executive Officer (June 10, 2026). Poxel is based in Lyon, Auvergne Rhône Alpes, France.

Who is the new Chief Executive Officer at Poxel?
Poxel named Yves Decadt Chief Executive Officer, announced June 10, 2026.
What did Poxel announce on June 10, 2026?
Poxel announces the appointment of Yves Decadt as Chief Executive Officer effective June 10, 2026. He succeeds Nicolas Trouche and aims to accelerate portfolio development and strategic partnerships.
What does Poxel do?
POXEL SA is a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic...
Where is Poxel based?
Poxel is based in Lyon, Auvergne Rhône Alpes, France.
Which similar companies made leadership changes around the same time?
Bristol Myers Squibb (June 17, 2026), Retension Pharmaceuticals (May 27, 2026), VistaGen (May 20, 2026) and PeptiDream (July 2, 2026) also announced leadership changes within 45 days of Poxel.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Poxel, and when

A new leader at Poxel brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Poxel raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Poxel, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Poxel. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Poxel

Location

Lyon, Auvergne Rhône Alpes, France

About

POXEL SA is a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Poxel changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Sylvie
Senior decision-maker at this company
••••••••@••••••••

See Sylvie's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Poxel's next move

Learn about Strategic plan

Poxel changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.